Terameprocol

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameTerameprocol
Drug Alias NameTMNDGATetra-O-methyl-NDGATetra-O-methyl nordihydroguaiaretic acidCINelimEM-1421 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsCNS Embryonal TumorSolid tumoursMyelodysplastic Syndromes +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins UniversityErimos Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesErimos Pharmaceuticals Llc
Inactive CompaniesUniversity Of California San FranciscoNational Cancer Institute
Active IndicationsGlioma
Inactive IndicationsCNS Embryonal TumorSolid tumoursMyelodysplastic Syndromes +[15] 

Other Information

ATC CodeN/A
Related LinksKEGG